» Articles » PMID: 20495576

The Colony-stimulating Factors and Cancer

Overview
Journal Nat Rev Cancer
Specialty Oncology
Date 2010 May 25
PMID 20495576
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

The four colony-stimulating factors (CSFs) are glycoproteins that regulate the generation and some functions of infection-protective granulocytes and macrophages. Recombinant granulocyte-CSF (G-CSF) and granulocyte-macrophage-CSF (GM-CSF) have now been used to increase dangerously low white blood cell levels in many millions of cancer patients following chemotherapy. These CSFs also release haematopoietic stem cells to the peripheral blood, and these cells have now largely replaced bone marrow as more effective populations for transplantation to cancer patients who have treatment-induced bone marrow damage.

Citing Articles

Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.

Pundavela J, Hall A, Dinglasan S, Choi K, Rizvi T, Trapnell B Cancers (Basel). 2025; 17(5).

PMID: 40075752 PMC: 11899227. DOI: 10.3390/cancers17050905.


CSF3 promotes colorectal cancer progression by activating p65/NF-κB signaling pathway and inducing an immunosuppressive microenvironment.

Xu J, Li N, Xie H, Duan C, Liao X, Li R Transl Oncol. 2025; 53:102310.

PMID: 39929064 PMC: 11849657. DOI: 10.1016/j.tranon.2025.102310.


Effect of colony‑stimulating factor in the mechanism of bone metastasis development (Review).

Han Y, Wang Y, Lv T, Yang Q, Cheng D, Li J Oncol Rep. 2024; 52(6).

PMID: 39422059 PMC: 11544585. DOI: 10.3892/or.2024.8824.


Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval.

Choi H, Choi A, Kopp J, Winkler C, Cho S J Korean Med Sci. 2024; 39(14):e134.

PMID: 38622939 PMC: 11018982. DOI: 10.3346/jkms.2024.39.e134.


Yeasts as Biopharmaceutical Production Platforms.

Kulagina N, Besseau S, Godon C, Goldman G, Papon N, Courdavault V Front Fungal Biol. 2023; 2:733492.

PMID: 37744146 PMC: 10512354. DOI: 10.3389/ffunb.2021.733492.


References
1.
LORD B, Molineux G, Pojda Z, Souza L, Mermod J, Dexter T . Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood. 1991; 77(10):2154-9. View

2.
Fairbairn L, Cowling G, Reipert B, Dexter T . Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 1993; 74(5):823-32. DOI: 10.1016/0092-8674(93)90462-y. View

3.
Molineux G, Pojda Z, Hampson I, LORD B, Dexter T . Transplantation potential of peripheral blood stem cells induced by granulocyte colony-stimulating factor. Blood. 1990; 76(10):2153-8. View

4.
Lieschke G, Grail D, Hodgson G, Metcalf D, Stanley E, Cheers C . Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994; 84(6):1737-46. View

5.
Bodey G, Buckley M, SATHE Y, Freireich E . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966; 64(2):328-40. DOI: 10.7326/0003-4819-64-2-328. View